In addition, the pigmented lesions in MC903-treated Braf/Pten ears quickly progressed to melanoma tumors at D45, whereas analogous melanomas were observed on EtOH-treated ears at a much later stage (at D70) (Figure 2D). The gene discussed is BRAF; the disease is melanoma.